Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
395.9 USD | +1.58% | +6.43% | +29.17% |
Apr. 24 | Baird Adjusts Medpace Price Target to $454 From $446, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Medpace Holdings, Inc., Q1 2024 Earnings Call, Apr 23, 2024 |
Financials (USD)
Sales 2024 * | 2.17B | Sales 2025 * | 2.52B | Capitalization | 12.24B |
---|---|---|---|---|---|
Net income 2024 * | 360M | Net income 2025 * | 418M | EV / Sales 2024 * | 5.31 x |
Net cash position 2024 * | 715M | Net cash position 2025 * | 1.04B | EV / Sales 2025 * | 4.44 x |
P/E ratio 2024 * |
35.4
x | P/E ratio 2025 * |
30.2
x | Employees | 5,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.84% |
Latest transcript on Medpace Holdings, Inc.
1 day | +1.58% | ||
1 week | +6.43% | ||
Current month | -2.03% | ||
1 month | -1.69% | ||
3 months | +32.79% | ||
6 months | +54.73% | ||
Current year | +29.17% |
Managers | Title | Age | Since |
---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 67 | 92-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 49 | 18-10-31 |
Jesse Geiger
PSD | President | 49 | 07-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Davenport
BRD | Director/Board Member | 72 | 18-08-12 |
August Troendle
CEO | Chief Executive Officer | 67 | 92-06-30 |
Director/Board Member | 64 | 18-08-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.15% | 2 M€ | -.--% | ||
0.49% | 0 M€ | 0.00% | - | |
0.40% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 395.9 | +1.58% | 144,681 |
24-04-25 | 389.8 | -1.96% | 313,834 |
24-04-24 | 397.6 | -2.36% | 423,451 |
24-04-23 | 407.2 | +8.21% | 808,514 |
24-04-22 | 376.3 | +1.15% | 357,745 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.17% | 12.24B | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
-3.12% | 11.76B | |
+6.35% | 11B | |
-16.98% | 10.07B |
- Stock Market
- Equities
- MEDP Stock